Which medicines do young children access from blister packs?

Elizabeth A Hender,* Corrine R Balit^†

1 Hazardous Substances Section, Environmental Health Service, Department of Health, PO Box 6 Rundle Mall, Adelaide, SA 5000
2 New South Wales Poisons Information Centre, The Children’s Hospital, Westmead, NSW.

Correspondence: elizabeth.hender@health.sa.gov.au

Acknowledgements:

Acknowledgement: The support of Judith Kirby and the specialists in poisons information at the NSWPIC is gratefully acknowledged.

1. O’Connor P. Accidental poisoning of preschool children from medicinal substances, Australia. Injury Research and Statistics Series No. 9. Adelaide: Australian Institute of Health and Welfare, 2002. (AIHW Catalogue No. INJCAT39.) Available at: http://www.nisu.flinders.edu.au/pubs/reports/2001/injcat39.pdf (accessed Nov 2004).
2. Rodgers GB. The safety effects of child-resistant packaging for oral prescription drugs. Two decades of experience. JAMA 1996; 275: 1661-1665.
3. Rodgers GB. The effectiveness of child-resistant packaging for aspirin. Arch Pediatr Adolesc Med 2002; 156: 929-933.
4. United States Consumer Product Safety Commission. Testing procedure for special packaging. In: Federal Regulations Associated with the Poison Prevention Packaging Act. Title 16 CFR Part 1700.20. Available at: http://www.access.gpo.gov/nara/cfr/waisidx_04/16cfr1700_04.html (accessed Nov 2004).
5. Therapeutic Goods Order No. 65. Child-resistant packaging for therapeutic goods. Canberra: Commonwealth of Australia, 2004. Available at: http://www.tga.gov.au/docs/html/tgo/tgo65.htm (accessed November 2004).

Online responses are no longer available. Please refer to our instructions for authors page for more information.